Search research articles
Contact Us
Filters
Showing results (11-20 of 171) with videos related to
Page
of 18
Sort By:
Health Policy (Amsterdam, Netherlands)
|
June 26, 2012
The vaccine gap between Japan and the UK
Rumiko Shimazawa, Masayuki Ikeda
Pharmacoepidemiology and Drug Safety
|
January 29, 2013
Safety information in drug labeling: a comparison of the USA, the UK, and Japan
Rumiko Shimazawa, Masayuki Ikeda
Expert Review of Molecular Diagnostics
|
February 18, 2020
Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan
Rumiko Shimazawa, Masayuki Ikeda
Environmental Health and Preventive Medicine
|
November 1, 2012
Steady state trials: another valid substitution of counterfactual ideal to measure causal effects
Okujou Iwami, Masayuki Ikeda
Health Security
|
March 28, 2015
Development of drug-approval regulations for medical countermeasures against CBRN agents in Japan
Rumiko Shimazawa, Masayuki Ikeda
Journal of Pharmaceutical Policy and Practice
|
December 14, 2019
Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes
Rumiko Shimazawa, Masayuki Ikeda
British Journal of Clinical Pharmacology
|
May 29, 2025
Consideration of ethnic differences in approvals for anti-HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post-marketing data
Rumiko Shimazawa, Masayuki Ikeda
Expert Review of Molecular Diagnostics
|
December 15, 2015
Drug-diagnostic co-development: challenges and issues
Rumiko Shimazawa, Masayuki Ikeda
Journal of General and Family Medicine
|
July 18, 2019
Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
Masayuki Ikeda, Rumiko Shimazawa
Psychiatry and Clinical Neurosciences
|
May 8, 2014
Conflicts of interest in psychiatry: strategies to cultivate literacy in daily practice
Rumiko Shimazawa, Masayuki Ikeda
Page
of 18
Search research articles
Search
Showing results (11-20 of 171) with videos related to
Sort By:
Page
of 18
Health Policy (Amsterdam, Netherlands)
|
June 26, 2012
The vaccine gap between Japan and the UK
Rumiko Shimazawa, Masayuki Ikeda
Pharmacoepidemiology and Drug Safety
|
January 29, 2013
Safety information in drug labeling: a comparison of the USA, the UK, and Japan
Rumiko Shimazawa, Masayuki Ikeda
Expert Review of Molecular Diagnostics
|
February 18, 2020
Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan
Rumiko Shimazawa, Masayuki Ikeda
Environmental Health and Preventive Medicine
|
November 1, 2012
Steady state trials: another valid substitution of counterfactual ideal to measure causal effects
Okujou Iwami, Masayuki Ikeda
Health Security
|
March 28, 2015
Development of drug-approval regulations for medical countermeasures against CBRN agents in Japan
Rumiko Shimazawa, Masayuki Ikeda
Journal of Pharmaceutical Policy and Practice
|
December 14, 2019
Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes
Rumiko Shimazawa, Masayuki Ikeda
British Journal of Clinical Pharmacology
|
May 29, 2025
Consideration of ethnic differences in approvals for anti-HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post-marketing data
Rumiko Shimazawa, Masayuki Ikeda
Expert Review of Molecular Diagnostics
|
December 15, 2015
Drug-diagnostic co-development: challenges and issues
Rumiko Shimazawa, Masayuki Ikeda
Journal of General and Family Medicine
|
July 18, 2019
Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
Masayuki Ikeda, Rumiko Shimazawa
Psychiatry and Clinical Neurosciences
|
May 8, 2014
Conflicts of interest in psychiatry: strategies to cultivate literacy in daily practice
Rumiko Shimazawa, Masayuki Ikeda
Page
of 18